Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine

International Journal of Oncology
Hong-Quan DuongInsoo Bae

Abstract

We describe the potential benefit of PIK-75 in combination of gemcitabine to treat pancreatic cancer in a preclinical mouse model. The effect of PIK-75 on the level and activity of NRF2 was characterized using various assays including reporter gene, quantitative PCR, DNA-binding and western blot analyses. Additionally, the combinatorial effect of PIK-75 and gemcitabine was evaluated in human pancreatic cancer cell lines and a xenograft model. PIK-75 reduced NRF2 protein levels and activity to regulate its target gene expression through proteasome-mediated degradation of NRF2 in human pancreatic cancer cell lines. PIK-75 also reduced the gemcitabine-induced NRF2 levels and the expression of its downstream target MRP5. Co-treatment of PIK-75 augmented the antitumor effect of gemcitabine both in vitro and in vivo. Our present study provides a strong mechanistic rationale to evaluate NRF2 targeting agents in combination with gemcitabine to treat pancreatic cancers.

References

Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Aug 12, 2003·International Journal of Gastrointestinal Cancer·Donghui Li, Li Jiao
Aug 30, 2003·American Journal of Surgery·Sarah M Cowgill, Peter Muscarella
Feb 6, 2004·The Journal of Pharmacology and Experimental Therapeutics·Shannon DallasReina Bendayan
Apr 4, 2007·The Journal of Biological Chemistry·Abhinav K Jain, Anil K Jaiswal
Jun 9, 2007·Biochimica Et Biophysica Acta·Massimo DonadelliMarta Palmieri
Dec 8, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Agnieszka LobodaJozef Dulak
Mar 27, 2009·Trends in Biochemical Sciences·John D Hayes, Michael McMahon
May 7, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shinsuke HommaMasayuki Yamamoto
Oct 2, 2009·Carcinogenesis·Thomas W Kensler, Nobunao Wakabayashi
Oct 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David CunninghamJohn P Neoptolemos
May 8, 2010·Antioxidants & Redox Signaling·John D HayesAlbena T Dinkova-Kostova
Sep 9, 2010·Neoplasia : an International Journal for Oncology Research·Wolfgang HagmannJohannes Matthias Löhr
Nov 9, 2010·Oncogene·A Martín-MontalvoR de Cabo
Jan 5, 2011·Current Opinion in Chemical Biology·Wooyoung Hur, Nathanael S Gray
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
May 31, 2011·Lancet·Audrey VincentMichael Goggins
Nov 26, 2011·Oncology·D MatthaiosS Kakolyris
Jun 13, 2012·Chemical Research in Toxicology·Thomas Müller, Arnd Hengstermann
Jul 20, 2012·Nature Reviews. Cancer·Michael B Sporn, Karen T Liby
Oct 31, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Phillip Shelton, Anil K Jaiswal
Dec 12, 2012·Biochemical Pharmacology·Holly K BryanB Kevin Park
Dec 29, 2012·Frontiers in Oncology·Yoichiro MitsuishiMasayuki Yamamoto
Jan 9, 2013·Annual Review of Pharmacology and Toxicology·Qiang Ma
Feb 26, 2013·Free Radical Biology & Medicine·Suryakant K NitureAnil K Jaiswal
Jul 17, 2013·Journal of Cellular and Molecular Medicine·Hong-Quan DuongInsoo Bae

❮ Previous
Next ❯

Citations

Jan 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Carole Nicco, Frédéric Batteux
Jan 18, 2018·Antimicrobial Agents and Chemotherapy·Dora PosfaiEmily R Derbyshire
Jul 21, 2015·Assay and Drug Development Technologies·Olivia PerwitasariRalph A Tripp
Jan 7, 2020·Current Topics in Medicinal Chemistry·Rammohan R Y Bheemanaboina
Sep 13, 2019·Cell Communication and Signaling : CCS·Jiang-Jiang QinWei-Dong Zhang
Jun 1, 2018·Oxidative Medicine and Cellular Longevity·Yukai XiangMengtao Zhou
Jun 18, 2017·Turkish Journal of Medical Sciences·Adile Ferda DağliSüleyman Serdar Koca
May 18, 2019·Oxidative Medicine and Cellular Longevity·Emiliano Panieri, Luciano Saso
Jan 29, 2020·Antioxidants & Redox Signaling·Katarína SmolkováPéter Bai
Jan 16, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aaron T ScottJames R Howe
Jan 7, 2021·Antioxidants & Redox Signaling·Emiliano Panieri, Luciano Saso
Oct 24, 2020·Trends in Pharmacological Sciences·Andrei-Florian StoicaSiim Pauklin
Mar 20, 2021·The Biochemical Journal·Silvia ArcucciJulie Guillermet-Guibert
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Pelin Telkoparan-AkillilarLuciano Saso

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
protein assay
X-ray
Assay
PCR
xenograft
ubiquitination

Software Mentioned

CompuSyn

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.